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Abstract
Cancer cells rely on glycolysis even under normoxic conditions.
The use of this pathway results in measurable intracellular
acidification, which is characterized as an early event in the
apoptosis program. The pH is restored by activation of voltagegated proton pumps, preventing acidification. Proton pump
inhibitors (PPIs), such as omeprazole, inhibit the H+/K+-ATPase
system found at the secretory surface of gastric parietal cells.
Research has shown that omeprazole is also capable of
inducing caspase-dependent apoptosis in Jurkat T-lymphocytes.
However, the effects of PPIs on caspase activity remain largely
unknown. The goal of this study was to determine the temporal
dynamics of caspase activity in Jurkat cells treated with
omeprazole, dexlansoprazole, or esomeprazole for six hours.
After the incubation period, cells were held in place by antiCD71 antibodies on the device’s affinity surface and
fluorescence microcopy was used to monitor caspase activity in
real time. Caspase activation was observed over a six-hour
period with the fluorogenic caspase probe, L-bisaspartic acid
rhodamine 110 (D2R). Elucidation of the intensity and timing of
caspase activation will be beneficial for evaluating PPIs as
potential cancer therapeutics.

Introduction
During mitochondrial apoptosis, caspases become active in a
signaling cascade (Fig. 1) (Susin et al., 2000). Cancer cells
upregulate proton pumps and hydrogen ion transporters (Huber
et al., 2010) to maintain alkalinity and avoid apoptosis. When
these methods of maintaining alkalinity are inhibited, the
intracellular space becomes too acidic and triggers apoptosis, a
form of programmed cell death.
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Temporal Dynamics Study
Cells incubated with 100mM PPI,
complete medium, & D2R at 37℃ and
5% CO2 for 6 hours
Cells re-suspended in complete
medium and D2R fluorophore
White light & fluorescence microscopy
images taken of aliquots from sample
every 3 hours for a total of 30 hours
Images processed with ImageJ
Fluorescence threshold established

•
•
•
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•
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•
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Results – Microfluidic Device Trials

Microfluidic Device Trials
Incubation repeated from prior study
Microfluidic devices (Fig. 2A) coated
with antibody ladder (Fig. 2B)
Cells adhered, white and green light
images taken for pre-wash photos
1x PBS wash for 5 minutes
Post-wash images taken
Imaging repeated every 6 hours
Images processed with ImageJ
Binding & apoptotic cell % determined

Figure 5: Percentage of bound cells for each drug by hour. PPI-treated cells all
show a dramatically reduced binding affinity after the 6-hour incubation period.

Conclusions

Figure 2A: Anatomy of a microfluidic device
attached to an inverted microscope.

Figure 2B: Antibody ladder to adhere cells to
the microfluidic device for observation.

Results – Temporal Dynamics

All three experimental drugs were shown to induce general
caspase activity in Jurkat cells within twenty-four hours of
exposure, with dexlansoprazole exhibiting comparable apoptotic
activity to doxorubicin at hour 27. Omeprazole and
esomeprazole showed a slower onset, but still reached 60%
apoptotic cells by hour 30. These results indicate that the tested
PPIs induce late-onset apoptosis in Jurkat cells following
treatment with 100mM of drug for 6 hours. Microfluidic device
trials revealed that drug-treated cells bind to the affinity surface
at a much lower percentage than the negative control cells,
suggesting that PPIs alter the cellular surface in some capacity.

Future Work

Figure 3: Percentage of apoptotic cells by hour for each drug. Error bars represent standard deviation for
three trials. Percent apoptosis corresponds to general caspase activity. Experimental drugs show
increased caspase activity over time, with dexlansoprazole showing comparable activity to the positive
control drug, doxorubicin (100µM), at hours 27 and 30.

Future studies may seek to:
• Verify cell death due to apoptosis via Annexin V staining
• Extend the window of observation beyond 30 hours
• Assess the apoptotic effects of other PPI drugs
• Characterize temporal dynamics of unique caspases
• Evaluate PPIs for their ability to induce caspase activity in
other cancer cell lines
• Explain disruptions to surface receptors following exposure
• Identify a suitable antibody for microfluidic device trials
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Figure 1: The signaling cascade of mitochondrial apoptosis (Susin et al., 2000).

Proton pump inhibitors (PPIs) inhibit gastric acid secretion by
inactivating proton pumps (Shin, 2008). Currently, PPIs are
utilized as supportive therapy in patients undergoing
chemotherapy. Prior research has shown that omeprazole
directly induces caspase-dependent apoptosis in Jurkat cells
(Scaringi, 2004), but the capability of PPIs to act as standalone
cancer treatments remains largely unevaluated. PPIs could
present a viable, less-toxic alternative to chemotherapeutics.

Initial microfluidic device trials seeking to observe caspase
activity were severely limited by low cell count. A study was
performed to determine if PPI treatment reduced binding affinity.
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Figure 4: T=0 fluorescence images (a-e), T=30 fluorescence images (f-j), and T=30 white light images
(k-o) for each sample. All experimental drugs showed visible fluorescence by hour thirty, compared to the
negative control. Dexlansoprazole and esomeprazole showed a high degree of aggregation that was not
observed with the other samples. Fluorescence images enhanced for clarity.
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